Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 3
Submit an article Journal homepage
164
Views
70
CrossRef citations to date
0
Altmetric
Original Article

Fractionated Cyclophosphamide, Vincristine, Liposomal Daunorubicin (Daunoxome), and Dexamethasone (HyperCVXD) Regimen in Richter's Syndrome

Bouthaina S. Dabaja Department of Leukemia, Houston, Texas, 77030, USA
,
Susan M. O'brien Department of Leukemia, Houston, Texas, 77030, USA
,
Hagop M. Kantarjian Department of Leukemia, Houston, Texas, 77030, USA
,
Jorge E. Cortes Department of Leukemia, Houston, Texas, 77030, USA
,
Deborah A. Thomas Department of Leukemia, Houston, Texas, 77030, USA
,
Maher Albitar Department of Pathology, Houston, Texas, 77030, USA
,
Ellen S. Schlette Department of Pathology, Houston, Texas, 77030, USA
,
Stefan Faderl Department of Leukemia, Houston, Texas, 77030, USA
,
Andreas Sarris Department of Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, USA
,
Michael J. Keating Department of Leukemia, Houston, Texas, 77030, USA
&
Francis J. Giles Department of Leukemia, Houston, Texas, 77030, USACorrespondence[email protected]
 show all
Pages 329-337 | Received 11 Nov 2000, Published online: 01 Jul 2009

References

  • Foucar K., Rydell R E. Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980; 46: 118–134
  • Armitage J, Dick O. FR, Corder M R. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer 1978; 41: 422–427
  • Harousseau J, Flandrin L., Tricot G., Brouet G., Seligmann C. J, Bernard M. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer 1981; 48: 1302–1308
  • Trump D, Mann L., Phelps B. R, Roberts R. H, Conley C L. Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature. Am J Med 1980; 68: 539–548
  • Giles F J, O'Brien S M, Keating M J. Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 1998; 25: 117–125
  • Murphy S, Bowman B., Abromowitch P. W, Mirro M., Ochs J., Rivera J. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732–1739
  • Kantarjian H M, O'Brien Smith S., Cortes L. T, Giles I., Beran J. F. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547–561
  • Janknegt R. Liposomal formulations of cytotoxic drugs. Support Care Cancer 1996; 4: 298–304
  • Wang Eksborg Y., Lewensohn S., Lindberg R., Liliemark A. In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells. Anticancer Drugs 1999; 10: 921–928
  • Richardson D, Kelsey S., Johnson M. S, Tighe A. S, Cavenagh M. JD, Newland A C. Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma. Invest New Drugs 1997; 15: 247–253
  • Robertson L, Pugh E., Kantarjian S., Hirsch H., GinsbergCork C. Richter's syndrome: a report on 39 patients. J Clin Oncol 1993; 11: 1985–1989
  • Sargent J, Elgie M., Williamson W. A, Lewandowicz J. CGM., Taylor C G. In vitro sensitivity to the liposomal preparation, DaunoXome in, CLL. Anticancer Res 1999; 19: 3253–3257
  • Flinn I, Goodman W., Post N. S, Jamison L., Miller J., Gore B. C, et al. A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced, NHL. Ann Oncol 2000; 11: 691–695
  • McLaughlin White P., Grillo A. C, Lopez A J, Maloney D G. Clinical status and optimal use of rituximab for B-cell lymphomas. Oncology (Huntingt) 1998; 12: 1763–1769, discussion 1769-1770, 1775-1767
  • Tsai Moore D., Hardy H., Porter C., Loh D., Vaughn E. D., et al. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation. Bone Marrow Transplant 1999; 24: 521–526
  • Yang Rosove H. MH, Figlin R A. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Am J Hematol 1999; 62: 247–250
  • Giles F J. Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants. Clin Infect Dis 1998; 26: 1282–1289
  • Chaperot Chokri L., Jacob M., Drillat C. M, Garban P., Egelhofer F. H., et al. Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma. Leukemia 2000; 14: 1667–1677

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.